Cost-effectiveness of single-dose tamsulosin and dutasteride combination therapy compared with tamsulosin monotherapy in patients with benign prostatic hyperplasia in the UK. [electronic resource]
Producer: 20131113Description: 638-46 p. digitalISSN:- 1464-410X
- 5-alpha Reductase Inhibitors -- economics
- Adrenergic alpha-1 Receptor Antagonists -- economics
- Azasteroids -- economics
- Cost-Benefit Analysis
- Disease Progression
- Drug Administration Schedule
- Drug Costs
- Drug Therapy, Combination
- Dutasteride
- Humans
- Male
- Markov Chains
- Middle Aged
- Practice Guidelines as Topic
- Prostatic Hyperplasia -- drug therapy
- Quality-Adjusted Life Years
- State Medicine -- economics
- Sulfonamides -- economics
- Tamsulosin
- Treatment Outcome
- United Kingdom -- epidemiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.